drugset / Trial / NCT01746732
A Study of Evacetrapib in Healthy Female Participants
RandomizedCrossoverOpen-labelBasic science
Summary
The purpose of this study is to evaluate the effects of evacetrapib on oral contraceptives (Ortho-Cyclen®) when given to healthy female participants. The amount of female hormones found in the blood will be measured and compared when taken alone and when taken with evaceptrapib. Each woman will participate in two study periods. Information about any side effects that may occur will also be collected.
Timeline
- Start
- 2012-12
- Primary completion
- 2013-05
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Evacetrapib | Small molecule | 130 mg | Oral |
| Subject | Ortho-Cyclen | Unknown | — | Oral |
Indications
No indication recorded.